Dipartimento di Anestesia, Rianimazione ed Emergenza-Urgenza, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
In December 2019, a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged in China and has spread globally, creating a pandemic. Information about the clinical characteristics of infected patients who require intensive care is limited.
To characterize patients with coronavirus disease 2019 (COVID-19) requiring treatment in an intensive care unit (ICU) in the Lombardy region of Italy.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective case series of 1591 consecutive patients with laboratory-confirmed COVID-19 referred for ICU admission to the coordinator center (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy) of the COVID-19 Lombardy ICU Network and treated at one of the ICUs of the 72 hospitals in this network between February 20 and March 18, 2020. Date of final follow-up was March 25, 2020.
SARS-CoV-2 infection confirmed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay of nasal and pharyngeal swabs.
Demographic and clinical data were collected, including data on clinical management, respiratory failure, and patient mortality. Data were recorded by the coordinator center on an electronic worksheet during telephone calls by the staff of the COVID-19 Lombardy ICU Network.
Of the 1591 patients included in the study, the median (IQR) age was 63 (56-70) years and 1304 (82%) were male. Of the 1043 patients with available data, 709 (68%) had at least 1 comorbidity and 509 (49%) had hypertension. Among 1300 patients with available respiratory support data, 1287 (99% [95% CI, 98%-99%]) needed respiratory support, including 1150 (88% [95% CI, 87%-90%]) who received mechanical ventilation and 137 (11% [95% CI, 9%-12%]) who received noninvasive ventilation. The median positive end-expiratory pressure (PEEP) was 14 (IQR, 12-16) cm H2O, and Fio2 was greater than 50% in 89% of patients. The median Pao2/Fio2 was 160 (IQR, 114-220). The median PEEP level was not different between younger patients (n = 503 aged ≤63 years) and older patients (n = 514 aged ≥64 years) (14 [IQR, 12-15] vs 14 [IQR, 12-16] cm H2O, respectively; median difference, 0 [95% CI, 0-0]; P = .94). Median Fio2 was lower in younger patients: 60% (IQR, 50%-80%) vs 70% (IQR, 50%-80%) (median difference, -10% [95% CI, -14% to 6%]; P = .006), and median Pao2/Fio2 was higher in younger patients: 163.5 (IQR, 120-230) vs 156 (IQR, 110-205) (median difference, 7 [95% CI, -8 to 22]; P = .02). Patients with hypertension (n = 509) were older than those without hypertension (n = 526) (median [IQR] age, 66 years [60-72] vs 62 years [54-68]; P < .001) and had lower Pao2/Fio2 (median [IQR], 146 [105-214] vs 173 [120-222]; median difference, -27 [95% CI, -42 to -12]; P = .005). Among the 1581 patients with ICU disposition data available as of March 25, 2020, 920 patients (58% [95% CI, 56%-61%]) were still in the ICU, 256 (16% [95% CI, 14%-18%]) were discharged from the ICU, and 405 (26% [95% CI, 23%-28%]) had died in the ICU. Older patients (n = 786; age ≥64 years) had higher mortality than younger patients (n = 795; age ≤63 years) (36% vs 15%; difference, 21% [95% CI, 17%-26%]; P < .001).
In this case series of critically ill patients with laboratory-confirmed COVID-19 admitted to ICUs in Lombardy, Italy, the majority were older men, a large proportion required mechanical ventilation and high levels of PEEP, and ICU mortality was 26%.
2019 年 12 月,一种新型冠状病毒(严重急性呼吸系统综合征冠状病毒 2 [SARS-CoV-2])在中国出现,并已在全球范围内传播,造成大流行。有关需要重症监护的感染患者的临床特征的信息有限。
描述意大利伦巴第地区需要入住重症监护病房(ICU)的 2019 年冠状病毒病(COVID-19)患者的特征。
设计、地点和参与者:这是一项回顾性病例系列研究,纳入了 1591 例连续确诊的 COVID-19 患者,这些患者经实时逆转录酶-聚合酶链反应(RT-PCR)检测鼻和咽拭子呈阳性,需要转入协调中心(米兰,意大利米兰的 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico),并在该网络的 72 家医院之一的 ICU 接受治疗。最终随访日期为 2020 年 3 月 25 日。
SARS-CoV-2 感染经实时 RT-PCR 检测鼻和咽拭子阳性证实。
收集了人口统计学和临床数据,包括临床管理、呼吸衰竭和患者死亡率的数据。COVID-19 伦巴第 ICU 网络的工作人员通过电话记录协调中心的电子工作表上的数据。
在这项研究中,纳入的 1591 例患者的中位(IQR)年龄为 63(56-70)岁,1304 例(82%)为男性。在 1043 例可获得数据的患者中,709 例(68%)至少有一种合并症,509 例(49%)患有高血压。在 1300 例可获得呼吸支持数据的患者中,1287 例(99%[95%CI,98%-99%])需要呼吸支持,包括 1150 例(88%[95%CI,87%-90%])接受机械通气和 137 例(11%[95%CI,9%-12%])接受无创通气。中位呼气末正压(PEEP)为 14(IQR,12-16)cm H2O,89%的患者 Fio2 大于 50%。中位 PaO2/Fio2 为 160(IQR,114-220)。年轻患者(n=503,年龄≤63 岁)和年长患者(n=514,年龄≥64 岁)的中位 PEEP 水平无差异(分别为 14[IQR,12-15]和 14[IQR,12-16]cm H2O;中位数差值,0[95%CI,0-0];P=0.94)。年轻患者的中位 Fio2 较低:60%(IQR,50%-80%)vs 70%(IQR,50%-80%)(中位数差值,-10%[95%CI,-14%至 6%];P=0.006),年轻患者的中位 PaO2/Fio2 较高:163.5(IQR,120-230)vs 156(IQR,110-205)(中位数差值,7[95%CI,-8 至 22];P=0.02)。患有高血压的患者(n=509)比没有高血压的患者(n=526)年龄更大(中位数[IQR]年龄,66 岁[60-72]vs 62 岁[54-68];P<0.001),PaO2/Fio2 更低(中位数[IQR],146[105-214]vs 173[120-222];中位数差值,-27[95%CI,-42 至-12];P=0.005)。截至 2020 年 3 月 25 日,可获得 ICU 处置数据的 1581 例患者中,920 例(58%[95%CI,56%-61%])仍在 ICU,256 例(16%[95%CI,14%-18%])已从 ICU 出院,405 例(26%[95%CI,23%-28%])已死亡。年龄较大的患者(n=786;年龄≥64 岁)的死亡率高于年龄较小的患者(n=795;年龄≤63 岁)(36%vs 15%;差异,21%[95%CI,17%-26%];P<0.001)。
在这项针对意大利伦巴第地区入住 ICU 的确诊 COVID-19 危重症患者的病例系列研究中,大多数患者为年龄较大的男性,其中很大一部分需要机械通气和高水平的 PEEP,ICU 死亡率为 26%。